<DOC>
<DOCNO>
EP-0016255
</DOCNO>
<TEXT>
<DATE>
19801001
</DATE>
<IPC-CLASSIFICATIONS>
C07D-413/04 A61P-25/02 A61P-25/00 C07D-413/00 A61P-11/08 <main>C07D-261/10</main> C07D-261/10 A61P-11/00 A61K-31/42 C07D-261/00 
</IPC-CLASSIFICATIONS>
<TITLE>
isoxazole derivative, preparation thereof and pharmaceutical compositions containing the same.
</TITLE>
<APPLICANT>
zambon spa it <sep>zambon s.p.a.<sep>zambon s.p.a.via lillo del duca, 10i-20091 bresso (milano)it<sep>zambon s.p.a. <sep>
</APPLICANT>
<INVENTOR>
chiarino dario<sep>della bella davide<sep>chiarino, dario<sep>della bella, davide<sep>chiarino, dariovia rivolta, 2i-20052 monza (milano)it<sep>della bella, davidepiazza leonardo da vinci, 3i-20133 milanoit<sep>chiarino, dario<sep>della bella, davide  <sep>chiarino, dariovia rivolta, 2i-20052 monza (milano)it<sep>della bella, davidepiazza leonardo da vinci, 3i-20133 milanoit<sep>
</INVENTOR>
<ABSTRACT>
1-(3-bromo-isoxazol-5-yl)-2-ter. butylaminoethanol  endowed with therapeutic activity, in particular bronchodilat­ ing action is disclosed, as well as a method for preparing same  from 3-bromo-5-isoxazolecarboxylic acid.  intermediate new  compounds as well as pharmaceutical compositions contain­ ing the novel isoxazole derivative are also disclosed.  
</ABSTRACT>
</TEXT>
</DOC>
